Bristol Myers Squibb
The Director, Bipolar Launch Lead (HCP) will serve as the primary commercial brand point for COBENFY's entry into the US bipolar disorder market, leading the translation of global strategy into a US launch plan and building the commercial and medical foundations for a best‑in‑class label expansion. This high‑visibility role partners with cross‑functional teams to shape pre‑ and post‑launch strategy, drive market development, and ensure integrated execution across neuroscience commercial functions.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
20% above the average for this role
Director, Global Marketing, Doravirine/Islatravir Commercialization & Launch Excellence
MSD
Sr. Director, HCP Marketing
Celldex Therapeutics
HCP Marketing Lead
Zenas BioPharma
Associate Director, HCP Marketing
Compass Pathways
Director, HCP Marketing (US, Rare Disease)
Alfasigma
Senior Director, HCP Marketing
lifelancer